Aura Biosciences, Inc. (AURA)
7.185
-0.18
(-2.38%)
USD |
NASDAQ |
Sep 09, 16:00
7.185
0.00 (0.00%)
After-Hours: 16:50
Aura Biosciences Market Cap : 743.50M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 761.61M |
| September 04, 2026 | 782.31M |
| September 03, 2026 | 762.65M |
| September 02, 2026 | 776.10M |
| September 01, 2026 | 768.86M |
| August 31, 2026 | 742.99M |
| August 28, 2026 | 765.75M |
| August 27, 2026 | 796.80M |
| August 26, 2026 | 799.90M |
| August 25, 2026 | 809.21M |
| August 24, 2026 | 817.49M |
| August 21, 2026 | 807.14M |
| August 20, 2026 | 804.04M |
| August 19, 2026 | 806.11M |
| August 18, 2026 | 844.40M |
| August 17, 2026 | 794.73M |
| August 14, 2026 | 795.76M |
| August 13, 2026 | 791.62M |
| August 12, 2026 | 801.97M |
| August 11, 2026 | 831.98M |
| August 10, 2026 | 796.80M |
| August 07, 2026 | 826.81M |
| August 06, 2026 | 798.87M |
| August 05, 2026 | 460.60M |
| August 04, 2026 | 458.68M |
| Date | Value |
|---|---|
| August 03, 2026 | 451.62M |
| July 31, 2026 | 449.70M |
| July 30, 2026 | 456.11M |
| July 29, 2026 | 449.70M |
| July 28, 2026 | 452.26M |
| July 27, 2026 | 459.32M |
| July 24, 2026 | 452.26M |
| July 23, 2026 | 461.88M |
| July 22, 2026 | 449.70M |
| July 21, 2026 | 450.98M |
| July 20, 2026 | 437.51M |
| July 17, 2026 | 448.41M |
| July 16, 2026 | 442.00M |
| July 15, 2026 | 449.70M |
| July 14, 2026 | 449.05M |
| July 13, 2026 | 449.05M |
| July 10, 2026 | 438.79M |
| July 09, 2026 | 449.05M |
| July 08, 2026 | 465.09M |
| July 07, 2026 | 450.98M |
| July 06, 2026 | 454.83M |
| July 02, 2026 | 496.52M |
| July 01, 2026 | 431.73M |
| June 30, 2026 | 455.47M |
| June 29, 2026 | 441.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.67B |
| Oncolytics Biotech, Inc. | 99.62M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.324B |
| Anixa Biosciences, Inc. | 96.34M |
Market Cap Related Metrics
| Price to Book Value | 2.358 |
| Price | 7.185 |
| Earnings Yield | -24.76% |